Nutra Pharma Comments on SEC Complaint
Contact: Nutra Pharma Corp. Nina Goldstein 877-895-5647 IR@nutrapharma.com Nutra Pharma is providing comments on the SEC Complaint filed...
Nutra Pharma announces updates with EuroAmerican IP & BioArmor, LLC, a Service Disabled Veteran-
Contact: Nutra Pharma Corp. Nina Goldstein 877-895-5647 IR@nutrapharma.com Nutra Pharma is providing an update on the work of...
Nutra Pharma Announces Agreement to Launch Comprehensive Internet Marketing Campaign
Contact: Nutra Pharma Corp. Nina Goldstein 877-895-5647 IR@nutrapharma.com Nutra Pharma is announcing its agreement with an Internet...
Nutra Pharma Announces Direct Mail Campaign for Pet Pain-Away™ Private Label Brand
Contact: Nutra Pharma Corp. Nina Goldstein 877-895-5647 IR@nutrapharma.com Nutra Pharma is announcing the next phase of marketing their...
Nutra Pharma Signs Definitive Letter of Intent for $4 Million Joint Venture Financing
Contact: Nutra Pharma Corp. Nina Goldstein 877-895-5647 IR@nutrapharma.com Nutra Pharma is announcing the execution of a Letter of Intent...
